Member Info for johnlaycock

But the Directors (ie those in the know, unlike the rest of us who can only speculate) clearly think things will happen in the short term with their collective and not insignificant Directors buys just before Christmas. That's the clearest signal you could hope for that near term news is on its way....

Looks like if we can get through 2.25p then straight to 2.4p, where there is some resistance.

Yes lots....hence the buying.

Why is it bad news for punters if any orders come through?!?!

Sorry 24 not 23!

I don't think it matters whether it's 18 or 23 months as I firmly believe that once international sales start happening (hopefully v soon), the NHS roll out starts from April for the stroke test and specialist commissioning is confirmed for the neonatal test again in April, the company will be taken over by a big boy.

Max12, are you saying it wasn't a sell?

I personally don't think it matters whether its 18 or 24 months, I suspect they will submit their findings/evidence at some point this year anyway.

You can't compare the two companys, GDR is on the cusp of mass commercialisation, SNG is still at test stage. The take up of any future fundraise is therefore likely to be hugely more attractive for us than unfortunately for SNG.

I think they are hoping the PALOH study will suffice for the FDA 's evidence requirements.

I think the CEX addressed the FDA pathway last month in the investor presentation?

I think the Scottish Technologies Group have already highlighted the cost saving to the NHS in Scotland of rolling out the two tests.

Directors purchasing shares in any company is a good sign and signals they have confidence in the future. Its for the birds to suggest they do it to create false confidence, they do it as they believe that their investment will increase, as anyone does that buys shares.

The Directors all bought in heavily last month, so why would they do that if they were planning a heavily discounted placing? They wouldn't.

Resistance at 2.4p first!

Yes I think we are at a very attractive entry point given all the positive news due.

Hi Jimi. Thanks, how do you know this?

News due v soon - its dangerous to be out as when the inevitable good RNS' land, we know this share will rocket!

I still can't work out why lab testing would be preferred given the Genedrive POC test is faster, more reliable and just as cost effective!

Https://www.theguardian.com/society/2025/jan/03/keir-starmer-to-unveil-radical-nhs-changes-to-cut-waiting-times